Abiopharma

New Form SCHEDULE 13G/A - BRIGHT MINDS BIOSCIENCES INC. Filed: 2025-05-15 AccNo: 0000950170-25-072739 Size: 10 KB

New Form SCHEDULE 13G/A - Applied Therapeutics, Inc. Filed: 2025-05-15 AccNo: 0001193805-25-000666 Size: 8 KB

New Form NT 10-Q - Hepion Pharmaceuticals, Inc. Filed: 2025-05-15 AccNo: 0001641172-25-010988 Size: 30 KB

New Form SCHEDULE 13G/A - OWENS & MINOR INC/VA/ Filed: 2025-05-15 AccNo: 0000950170-25-072742 Size: 14 KB

New Form SCHEDULE 13G/A - Amylyx Pharmaceuticals, Inc. Filed: 2025-05-15 AccNo: 0000950170-25-072740 Size: 10 KB

New Form NT 10-Q - iCoreConnect Inc. Filed: 2025-05-15 AccNo: 0001477932-25-003822 Size: 22 KB

Notification from Tenax Therapeutics

Globus Medical Announces $500 Million Share Repurchase Program

Delcath Systems to Participate at the Craig-Hallum 22nd Annual Investor Conference

New Form SCHEDULE 13G/A - Instil Bio, Inc. Filed: 2025-05-15 AccNo: 0000950170-25-072725 Size: 10 KB

New Form SCHEDULE 13G/A - Strawberry Fields REIT, Inc. Filed: 2025-05-15 AccNo: 0001172661-25-002389 Size: 10 KB

New Form SCHEDULE 13G - BIODESIX INC Filed: 2025-05-15 AccNo: 0000950170-25-072726 Size: 30 KB

New Form SCHEDULE 13G/A - Praxis Precision Medicines, Inc. Filed: 2025-05-15 AccNo: 0000950170-25-072732 Size: 10 KB

New Form 6-K - Biodexa Pharmaceuticals Plc Filed: 2025-05-15 AccNo: 0001214659-25-007894 Size: 49 KB

New Form SCHEDULE 13G/A - Evolus, Inc. Filed: 2025-05-15 AccNo: 0000950170-25-072731 Size: 10 KB